drugset / Trial / NCT01223742

Oral Acetyl-L-Carnitine Therapy Reduces Fatigue In Hepatic Encephalopathy

NCT01223742

Summary

The aim of this study was to evaluate the effect of exogenous ALC on the both physical and mental fatigue in mild and moderate encephalopatic patients.

Timeline

Start
2002-06
Primary completion
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetylcarnitine Small molecule 2 g Oral